KBC Group NV Takes Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

KBC Group NV bought a new position in Clover Health Investments, Corp. (NASDAQ:CLOV) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 18,658 shares of the company’s stock, valued at approximately $53,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CLOV. Forum Financial Management LP lifted its holdings in shares of Clover Health Investments by 33.8% during the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after buying an additional 4,061 shares during the period. Bleakley Financial Group LLC raised its position in Clover Health Investments by 98.9% in the 3rd quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company’s stock worth $57,000 after purchasing an additional 9,988 shares during the period. Concurrent Investment Advisors LLC purchased a new position in Clover Health Investments in the 3rd quarter worth about $28,000. Sigma Planning Corp bought a new stake in Clover Health Investments during the 3rd quarter valued at $29,000. Finally, SignalPoint Asset Management LLC raised its holdings in shares of Clover Health Investments by 8.1% in the 3rd quarter. SignalPoint Asset Management LLC now owns 150,684 shares of the company’s stock valued at $425,000 after purchasing an additional 11,318 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors.

Clover Health Investments Stock Performance

Clover Health Investments stock opened at $3.37 on Friday. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.71. The business’s 50-day simple moving average is $3.59 and its two-hundred day simple moving average is $2.36. The company has a market cap of $1.69 billion, a PE ratio of -16.85 and a beta of 2.03.

Clover Health Investments (NASDAQ:CLOV) last posted its earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.01. The firm had revenue of $330.99 million during the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same period in the previous year, the firm earned ($0.09) EPS. As a group, analysts predict that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, UBS Group assumed coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 target price for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.